Know Cancer

or
forgot password
  • cancer clinical trials in washington, NC

  • Chemotherapy Decisions and Outcomes in Older Women With Newly Diagnosed Breast Cancer
    Marion L. Shepard Cancer Center at Beaufort County Hospital
    Washington, North Carolina 27889
    Breast Cancer, Psychosocial Effects of Cancer and Its Treatment
    Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
    Marion L. Shepard Cancer Center at Beaufort County Hospital
    Washington, North Carolina 27889
    Breast Cancer
    Four Versus Six Cycles of Cyclophosphamide/Doxorubicin or Paclitaxel in Adjuvant Breast Cancer
    Marion L. Shepard Cancer Center at Beaufort County Hospital
    Washington, North Carolina 27889
    Breast Cancer
    Comparison of Combination Chemotherapy Regimens With or Without Cetuximab in Treating Patients Who Have Undergone Surgery For Stage III Colon Cancer
    Marion L Shepard Cancer Center
    Washington, North Carolina 27889
    Adenocarcinoma of the Colon, Stage III Colon Cancer
    Docetaxel and Prednisone With or Without Atrasentan in Treating Patients With Stage IV Prostate Cancer and Bone Metastases That Did Not Respond to Previous Hormone Therapy
    Marion L. Shepard Cancer Center at Beaufort County Hospital
    Washington, North Carolina 27889
    Metastatic Cancer, Prostate Cancer
    A Study Comparing Bevacizumab Therapy With or Without Erlotinib for First-Line Treatment of Non-Small Cell Lung Cancer (ATLAS)
    Beaufort County Hospital
    Washington, North Carolina 27889
    Non-Small Cell Lung Cancer
    Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer
    Marion L. Shepard Cancer Center at Beaufort County Hospital
    Washington, North Carolina 27889
    Colorectal Cancer
    Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial)
    Marion L Shepard Cancer Center
    Washington, North Carolina 27889
    Estrogen Receptor-positive Breast Cancer, HER2-negative Breast Cancer, Progesterone Receptor-positive Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIB Breast Cancer
    Letrozole in Treating Postmenopausal Women Who Have Received Hormone Therapy for Hormone Receptor-Positive Breast Cancer
    Marion L. Shepard Cancer Center at Beaufort County Hospital
    Washington, North Carolina 27889
    Breast Cancer
    Chemotherapy With or Without Bevacizumab in Treating Women With Stage I, Stage II, or Stage IIIA Breast Cancer That Can Be Removed By Surgery
    Marion L. Shepard Cancer Center at Beaufort County Hospital
    Washington, North Carolina 27889
    Breast Cancer
    Doxorubicin, Cyclophosphamide, and Paclitaxel With or Without Bevacizumab in Treating Patients With Lymph Node-Positive or High-Risk, Lymph Node-Negative Breast Cancer
    Marion L Shepard Cancer Center
    Washington, North Carolina 27889
    Male Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Cancer, Stage IIIB Breast Cancer
    Pemetrexed and/or Sunitinib as Second-Line Therapy in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
    Marion L Shepard Cancer Center
    Washington, North Carolina 27889
    Recurrent Non-small Cell Lung Cancer, Stage IIIB Non-small Cell Lung Cancer, Stage IV Non-small Cell Lung Cancer
    Paclitaxel, Paclitaxel Albumin-Stabilized Nanoparticle Formulation, or Ixabepilone With or Without Bevacizumab in Treating Patients With Stage IIIC or Stage IV Breast Cancer
    Marion L Shepard Cancer Center
    Washington, North Carolina 27889
    Male Breast Cancer, Recurrent Breast Cancer, Stage IIIC Breast Cancer, Stage IV Breast Cancer
    Gemcitabine Hydrochloride or Pemetrexed Disodium and Carboplatin With or Without Celecoxib in Treating Patients With Advanced Non-Small Cell Lung Cancer
    Marion L. Shepard Cancer Center at Beaufort County Hospital
    Washington, North Carolina 27889
    Lung Cancer
    Registry of Older Patients With Cancer
    Marion L. Shepard Cancer Center
    Washington, North Carolina
    Chronic Myeloproliferative Disorders, Cognitive/Functional Effects, Leukemia, Lymphoma, Lymphoproliferative Disorder, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Neoplasms, Unspecified Adult Solid Tumor, Protocol Specific
    Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Celecoxib in Treating Patients With Stage III Colon Cancer Previously Treated With Surgery
    Marion L. Shepard Cancer Center at Beaufort County Hospital
    Washington, North Carolina 27889
    Colorectal Cancer
    Biomarker-Guided Fluorouracil in Treating Patients With Colorectal Cancer Receiving Combination Chemotherapy
    Marion L. Shepard Cancer Center
    Washington, North Carolina
    Colorectal Cancer, Diarrhea, Neutropenia
    Everolimus With or Without Bevacizumab in Treating Patients With Advanced Kidney Cancer That Progressed After First-Line Therapy
    Marion L Shepard Cancer Center
    Washington, North Carolina 27889
    Clear Cell Renal Cell Carcinoma, Recurrent Renal Cell Cancer, Stage III Renal Cell Cancer, Stage IV Renal Cell Cancer
    Bendamustine + Rituximab in Older Patients With Previously Untreated Diffuse Large B-cell Lymphoma
    Marion L. Shepard Cancer Center
    Washington, North Carolina
    Diffuse Large B-Cell Lymphoma, Lymphoma, Diffuse Large-Cell, Diffuse Large-Cell Lymphoma, Lymphoma
    Chemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast Cancer
    Marion L Shepard Cancer Center
    Washington, North Carolina 27889
    Estrogen Receptor-negative Breast Cancer, Estrogen Receptor-positive Breast Cancer, HER2-positive Breast Cancer, Progesterone Receptor-negative Breast Cancer, Progesterone Receptor-positive Breast Cancer, Recurrent Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Cancer, Stage IIIC Breast Cancer
    Regorafenib+FOLFIRI Versus Placebo+FOLFIRI as 2nd Line Tx in Metastatic Colorectal Cancer
    Marion L. Shepard Cancer Center
    Washington, North Carolina
    Colorectal Cancer Metastatic
    A Study Of Everolimus, Trastuzumab And Vinorelbine In HER2-Positive Breast Cancer Brain Metastases
    Marion L. Shepard Cancer Center
    Washington, North Carolina
    HER-2 Positive Breast Cancer
    Cabazitaxel Versus Docetaxel Both With Prednisone in Patients With Metastatic Castration Resistant Prostate Cancer
    Investigational Site Number 840011
    Washington, North Carolina 27889
    Prostate Cancer
    Trial Evaluating Dovitinib Combined With Fulvestrant, in Postmenopausal Patients With HER2- and HR+ Breast Cancer
    Marion L. Shepard Cancer Center
    Washington, North Carolina
    Metastatic Breast Cancer
    The Plenaxis® Experience Study
    Washington Urological Associates
    Washington, North Carolina 27889
    Prostate Cancer
    Weekly vs. Every 2 Week vs. Every 3 Week Administration of ABI-007 (Abraxane)/Bevacizumab Combination in Metastatic Breast Cancer
    Marion L. Shepard Cancer Center
    Washington, North Carolina
    Breast Neoplasms, Neoplasm Metastasis
    Randomized Study Evaluating Ixabepilone Plus Capecitabine or Docetaxel Plus Capecitabine in Metastatic Breast Cancer
    Marion L Shepard Cancer Center
    Washington, North Carolina 27889
    Breast Neoplasms
    Effect of Zoledronic Acid as Anti-Cancer Treatment in Metastatic Breast Cancer Patients
    Marion L. Shepard Cancer Center
    Washington, North Carolina
    First or Second Line HER2-negative Breast Cancer, Metastatic Disease Without Bone Metastasis